Conferences \ Circulating Biomarkers World Congress 2016 \ Agenda \ Xandra Breakefield |
Register | Login |
New Dimensions of Extracellular Vesicles – Cell Biopsies and Therapeutic VehiclesMonday, 21 March 2016 at 10:00 Add to Calendar ▼SELECTBIOenquiries@selectbiosciences.com The contributions of EVs to medicine continues to expand. These vesicles are virtual biopsies of living cells in the body that report on their dynamic physiology through an array of proteins, DNA and RNA. This array is unique to EVs and accessible through biofluids, with profiles informative for different disease states and response to therapy. These vesicles can also be used as stealth vehicles to deliver bioactive agents, including drugs and genes. Their innate stability in vivo, robust loading capacity and ability to achieve efficient delivery to different tissues expands therapeutic modalities. New Dimensions of Extracellular Vesicles – Cell Biopsies and Therapeutic VehiclesMonday, 21 March 2016 at 10:00 Add to Calendar ▼SELECTBIOenquiries@selectbiosciences.com The contributions of EVs to medicine continues to expand. These vesicles are virtual biopsies of living cells in the body that report on their dynamic physiology through an array of proteins, DNA and RNA. This array is unique to EVs and accessible through biofluids, with profiles informative for different disease states and response to therapy. These vesicles can also be used as stealth vehicles to deliver bioactive agents, including drugs and genes. Their innate stability in vivo, robust loading capacity and ability to achieve efficient delivery to different tissues expands therapeutic modalities. New Dimensions of Extracellular Vesicles – Cell Biopsies and Therapeutic VehiclesMonday, 21 March 2016 at 10:00 Add to Calendar ▼SELECTBIOenquiries@selectbiosciences.com The contributions of EVs to medicine continues to expand. These vesicles are virtual biopsies of living cells in the body that report on their dynamic physiology through an array of proteins, DNA and RNA. This array is unique to EVs and accessible through biofluids, with profiles informative for different disease states and response to therapy. These vesicles can also be used as stealth vehicles to deliver bioactive agents, including drugs and genes. Their innate stability in vivo, robust loading capacity and ability to achieve efficient delivery to different tissues expands therapeutic modalities. |